Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Aging Clinical and Experimental Research|November 3, 2023
Overweight in elderly increases postural instability during sit-to-stand test: a Kinect-based assessmentWeerasak Tapanya, Sirintip Kumfu, Noppharath Sangkarit, et al.
Annals of Geriatric Medicine and Research|August 18, 2023
Balance Ability and Quality of Life in Older Adult with Recovery from Mild COVID-19Patchareeya Amput, Weerasak Tapanya, Noppharath Sangkarit, et al.
Annals of Rehabilitation Medicine|February 7, 2024
Predicting Age of Independent Walking in Preterm Infants: A Longitudinal Study Using Neonatal Characteristics and Motor Development VariablesNoppharath Sangkarit, Weerasak Tapanya, Arunrat Srithawong, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular functionPatchareeya Amput, Christian McSweeney, Siripong Palee, et al.
European Journal of Pharmacology|July 11, 2020
PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant ratsPatchareeya Amput, Siripong Palee, Busarin Arunsak, et al.
Journal of Cellular and Molecular Medicine|July 7, 2020
PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca<sup>2+</sup> regulationPatchareeya Amput, Siripong Palee, Busarin Arunsak, et al.
Toxicology and Applied Pharmacology|September 2, 2019
The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female ratsChanisa Thonusin, Nattayaporn Apaijai, Thidarat Jaiwongkam, et al.
Menopause (New York, N.Y.)|June 25, 2020
A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived ratsChanisa Thonusin, Patcharapong Pantiya, Thidarat Jaiwongkam, et al.
Archives of Biochemistry and Biophysics|June 28, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese ratsBusarin Arunsak, Wasana Pratchayasakul, Patchareeya Amput, et al.
Pageof 3